In conclusion, lnc‐ITSN1‐2 is highly expressed and correlates with inflammation, multiple organ dysfunction, and mortality risk in sepsis patients, indicating lnc‐ITSN1‐2 may serve as a potential biomarker in sepsis patients. This evidence concerns the gene ITSN1 and Sepsis.